cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Solid Biosciences Inc
12 own
27 watching
Current Price
$0
$-0.01
(-0.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
56.57M
52-Week High
52-Week High
21.45
52-Week Low
52-Week Low
5.21
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization56.57M
icon52-Week High21.45
icon52-Week Low5.21
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Solid Biosciences Inc do?
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company s lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Solid Biosciences Inc make?
News & Events about Solid Biosciences Inc.
Globe Newswire
8days ago
- Publication in Human Gene Therapy provides rationale for the use of microdystrophin expression levels as a surrogate endpoint reasonably likely to predict clinical benefit for AAV gene therapy intended for treatment of patients with Duchenne muscular dystrophy - - White paper submitted to the U.S...
Globe Newswire
23days ago
Research collaboration to target severe form of genetic dilated cardiomyopathyCollaboration strengthens Solid Biosciences scientific capabilities and commercial potential in cardiac therapyCollaboration allows Phlox Therapeutics to leverage Solid Biosciences vector biology and manufacturing ...
Globe Newswire
24days ago
Investigational New Drug (IND) application for SGT-003, next-generation gene therapy for Duchenne muscular dystrophy utilizing novel capsid AAV-SLB101, expected in 2H-2023 Candidate selection and transition manufacturing process to transient transfection for AVB-202 for Friedrich's Ataxia and AVB ...
Globe Newswire
25days ago
CHARLESTOWN, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced the appointment of Kevin Tan, CFA, a seasoned industry professional, as Chief Financial Officer. ...
Globe Newswire
25days ago
CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan ...
Frequently Asked Questions
Frequently Asked Questions
What is Solid Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Solid Biosciences Inc shares?
plus_minus_icon
How can I buy Solid Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Solid Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Solid Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Solid Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Solid Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Solid Biosciences Inc?
plus_minus_icon
What percentage is Solid Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Solid Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.01
(-0.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00